Gene expression cassette and application thereof in preparation of recombinant collagen
By modifying the gene expression system of Corynebacterium glutamicum and utilizing promoter screening, RBS and AS optimization, and tandem combination of gene expression cassettes, the expression difficulties and purification complexity of the existing expression system were solved, achieving high-yield and structurally stable recombinant collagen production.
Patent Information
- Application Number
- CN202410363606.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-03-28
- Publication Date
- 2025-09-30
AI Technical Summary
The existing Escherichia coli and Pichia pastoris expression systems have problems with intracellular expression, complex purification, long expression cycle, and difficulty in forming a triple helix structure when expressing recombinant collagen. In addition, the Corynebacterium glutamicum system has deficiencies in secretory expression and purification, making it difficult to meet the needs of industrial production.
Corynebacterium glutamicum was used as the expression system. Through promoter screening, ribosome binding site (RBS) and spacer sequence (AS) modification, and construction of a tandem combination of gene expression cassettes, the secretory expression of collagen was optimized, and its yield and structural stability were improved.
The collagen production of Corynebacterium glutamicum was significantly improved. The collagen production of the constructed recombinant strain reached a maximum of 697 mg/L, which was 6 times higher than that of the unmodified strain, ensuring the structure and stability of the protein.
Smart Images

Figure CN120718910A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a gene expression cassette and application thereof in preparing recombinant collagen, belonging to the field of molecular biology. Background Art
[0002] Collagen is one of the most abundant and widely distributed functional proteins in the human body, comprising approximately one-third of the body's total protein. It is primarily found in mammalian tissues, including skin, bones, muscles, blood vessels, and tendons, and is a key component of animal connective tissue and the extracellular matrix. Collagen is composed of three identical L-polyproline α-helical peptide chains, twisted around a central axis with one residue offset to form a right-handed triple helix. Collagen's stable triple helix structure imparts excellent biomechanical properties and biocompatibility, leading to its widespread application in biomedicine, tissue engineering, the food industry, cosmetics, and numerous other fields.
[0003] Currently, the main ways to obtain collagen include traditional animal tissue extraction, chemical synthesis, animal and plant production, and microbial recombinant expression. Traditional animal tissue extraction is the most common method, but there may be risks of immunogenicity and potential pathogen infection. Although chemical synthesis can accurately design and synthesize collagen polypeptides, the synthesis process is complex and the cost is high, and the length of the triple helix peptide is far less than that of natural collagen. Both animal and plant production and microbial recombinant expression use genetic engineering technology to introduce collagen genes into host cells for expression. Among them, microbial recombinant expression has higher production efficiency and lower production costs, and is particularly suitable for large-scale industrial production. In recent years, advances in synthetic biology have provided highly customizable tools. At the same time, efficient microbial expression systems have significantly improved protein production efficiency. Microbial expression of recombinant collagen has broad application prospects.
[0004] Currently, commonly used microbial expression systems for recombinant collagen include Escherichia coli and Pichia pastoris. Expression of Scl2, a collagen protein derived from Streptococcus pyogenes (S. pyogenes), in E. coli resulted in shake flask yields of 300 mg / L and fermenter yields of up to 19 g / L. Furthermore, the protein maintained a stable triple-helical structure in the absence of proline hydroxylase modification. Through response surface optimization, optimization of culture medium composition, and batch fermentation conditions, yields of human-like type III collagen in E. coli and Pichia pastoris reached 9.68 g / L and 4.71 g / L, respectively. Furthermore, recombinant collagen synthesized from a hydrophilic fragment of human type I collagen achieved fermenter yields of up to 4.5 g / L in Pichia pastoris.
[0005] However, both expression systems have some defects. The E. coli expression system is mostly intracellular when expressing exogenous proteins, and the large amount of endogenous proteins and endotoxins produced at the same time will bring difficulties to downstream purification. The Pichia pastoris expression system has a long expression cycle and is not easy to secrete the collagen protein forming a triple helical structure outside the cell. Relatively speaking, Corynebacterium glutamicum, as a host that meets food safety standards, has received more and more attention due to its significant advantages in secretory expression and purification. In the field of cell engineering, the regulation of gene expression is crucial for metabolic engineering. E. coli inducible promoters such as tac, lacUV5, trc, etc. have been widely used for gene expression in Corynebacterium glutamicum. In addition, ribosome binding sites (RBS) and spacer sequences (AS) also have an important impact on the translation level of mRNA.
[0006] To achieve secretory expression of triple-helical collagen, the inventors initially selected a collagen fragment B sequence from the Streptococcus pyogenes collagen-like protein Scl2. After signal peptide screening and optimization of fermentation conditions, the expression level of recombinant collagen VB was increased to 67.3 mg / L, but the expression level remained relatively low. Therefore, using Corynebacterium glutamicum as an expression host to produce collagen and further increase its yield has high practical and economic value, making it suitable for the safe and rapid production of recombinant collagen in industrial applications. Summary of the Invention
[0007] To solve the above problems, the present invention uses Corynebacterium glutamicum as an expression system, and through promoter screening, ribosome binding site (RBS), spacer sequence (AS) modification and tandem combination of gene expression cassettes, the structure and stability of the protein are ensured while further improving the collagen (VB) production of Corynebacterium glutamicum.
[0008] The present invention uses collagen (VB) as a model protein. The protein is disclosed in the patent "CN114480409B: A signal peptide and a method for promoting secretory expression of collagen in Corynebacterium glutamicum" and the document "Dissecting a BacterialCollagen Domain from Streptococcus pyogenes: sequence and length-dependent variations in triple helix stability and folding". The amino acid sequence of collagen (VB) is shown in SEQ ID NO.1, and the nucleotide sequence is shown in SEQ ID NO.2, wherein V represents the folding domain and B represents the collagen domain.
[0009] The AS sequence is located after the RBS sequence. The present invention refers to the modification of RBS and AS by mutation based on the RBS seed region to construct a sequence containing AAAGGAN (6-9) A mutation library, where N (6-9) is 6 to 9 random bases, N (6-9) Contains AS sequence.
[0010] The tandem combination of gene expression cassettes in the present invention refers to the insertion of multiple target gene expression units with the same sequence after the promoter and operator; wherein the structure of the target gene expression unit is: RBS sequence (including AS sequence) - signal peptide - target gene; the tandem combination of multiple target gene expression units can increase the copy number of the target gene in the host cell.
[0011] The first object of the present invention is to provide a gene expression cassette, the structure of which comprises:
[0012] Promoter-(ribosome binding site-target protein) n -Terminator;
[0013] Wherein, n represents quantity, and the value of n is 1, 2, 3 or 4; the nucleotide sequence of RBS is shown in SEQ ID NO.26, SEQ ID NO.27, SEQ ID NO.28, SEQ ID NO.29, SEQ ID NO.30, SEQ ID NO.31, SEQ ID NO.32, SEQ ID NO.33, SEQ ID NO.34 or SEQ ID NO.35.
[0014] In one embodiment, the promoter, ribosome binding site, target protein, and terminator in the gene expression cassette structure all refer to nucleotide sequences.
[0015] In one embodiment, the promoter includes: tac, tacM, P7, NCgl1676, NCgl0226, sod, H36, H10. Alternatively, the promoter is tac, tacM.
[0016] In one embodiment, the nucleotide sequence of the promoter tac is shown as SEQ ID NO.58; the nucleotide sequence of the promoter tacM is shown as SEQ ID NO.59.
[0017] In one embodiment, when the promoter is tac, an RBS sequence as shown in SEQ ID NO.26, SEQ ID NO.27, SEQ ID NO.28, SEQ ID NO.29 or SEQ ID NO.30 is used; when the promoter is tacM, an RBS sequence as shown in SEQ ID NO.31, SEQ ID NO.32, SEQ ID NO.33, SEQ ID NO.34 or SEQ ID NO.35 is used.
[0018] In one embodiment, the promoters tac and tacM are inducible promoters that require isopropyl-β-D-thiogalactoside (IPTG) to induce expression.
[0019] In one embodiment, the target protein includes: collagen and enzyme.
[0020] In one embodiment, the amino acid sequence of the collagen is shown as SEQ ID NO. 1, and the nucleotide sequence is shown as SEQ ID NO. 2. Alternatively, the amino acid sequence of the collagen can also be shown as any one of SEQ ID NOs. 60-66.
[0021] In one embodiment, an operator is further connected between the promoter and the ribosome binding site, and the nucleotide sequence of the operator is located in the nucleotide sequence of the promoter.
[0022] In one embodiment, the operon includes common operons such as the lactose operon and the tryptophan operon. Optionally, it is the lactose operon.
[0023] In one embodiment, the nucleotide sequence of the lactose operon is shown as SEQ ID NO.3.
[0024] In one embodiment, a signal peptide nucleotide sequence is further connected between the ribosome binding site and the target protein.
[0025] In one embodiment, the nucleotide sequence of the signal peptide (porB) is shown as SEQ ID NO.4.
[0026] In one embodiment, a target gene expression unit is composed of RBS sequence-signal peptide-target gene.
[0027] In one embodiment, the nucleotide sequence of the terminator is UAA.
[0028] A second object of the present invention is to provide a plasmid or cell carrying any of the above gene expression cassettes.
[0029] In one embodiment, the cells include yeast, mold, mammalian cells, insect cells, plant cells, Escherichia coli, Corynebacterium glutamicum, Bacillus subtilis, Serratia marcescens, and lactic acid bacteria. Optionally, the cells are Corynebacterium glutamicum.
[0030] The present invention also provides use of any of the above gene expression cassettes or plasmids or cells in preparing collagen.
[0031] The present invention also provides a recombinant bacterium, the recombinant Corynebacterium glutamicum containing the above-mentioned gene expression cassette; wherein the value of n is 1, 2, 3 or 4, the promoter is tac, the nucleotide sequence of the promoter is shown in SEQ ID NO.58, the nucleotide sequence of the ribosome binding site is shown in any one of SEQ ID NOs.25 to 30, and the amino acid sequence of the target protein is shown in SEQ ID NO.1; optionally, the recombinant bacterial host is Corynebacterium glutamicum, the expression vector of the gene expression cassette in the recombinant bacterium is the plasmid pXMJ19-PorB-VB, and the amino acid sequence of the target protein can also be shown in any one of SEQ ID NOs.60 to 66.
[0032] In one embodiment, a lactose operon is connected between the promoter and the ribosome binding site, and the nucleotide sequence is shown in SEQ ID NO.3; a signal peptide nucleotide sequence is connected between the ribosome binding site and the target protein, and the nucleotide sequence is shown in SEQ ID NO.4.
[0033] In one embodiment, the structure in the gene expression cassette is:
[0034] tac promoter-lactose operator-(RBS sequence shown in SEQ ID NO.30, nucleotide sequence shown in SEQ ID NO.2, collagen) 1, the nucleotide sequence of the above structure is shown in SEQ ID NO.67.
[0035] In one embodiment, when the value of n in the gene expression cassette is 2, the nucleotide sequence in the gene expression cassette is shown as SEQ ID NO.56; when the value of n is 4, the nucleotide sequence in the gene expression cassette is shown as SEQ ID NO.57.
[0036] A third object of the present invention is to provide a method for increasing collagen production, wherein collagen is prepared by fermentation using recombinant Corynebacterium glutamicum, wherein the recombinant Corynebacterium glutamicum contains any of the above-mentioned gene expression cassettes; wherein the value of n is 1, 2, 3 or 4, and the nucleotide sequence of the ribosome binding site is as shown in any one of SEQ ID NOs. 26 to 30.
[0037] In one embodiment, the promoter in the gene expression cassette is: tac, tacM, P7, NCgl1676, NCgl0226, sod, H36, H10; optionally, the promoter is tac or tacM.
[0038] In one embodiment, the target protein in the gene expression cassette is collagen, and the amino acid sequence of the collagen is shown in SEQ ID NO.1, SEQ ID NO.60, SEQ ID NO.61, SEQ ID NO.62, SEQ ID NO.63, SEQ ID NO.64, SEQ ID NO.65 or SEQ ID NO.66.
[0039] In one embodiment, an operator is further connected between the promoter and the ribosome binding site, and the nucleotide sequence of the operator is shown in SEQ ID NO.3; a signal peptide nucleotide sequence is further connected between the ribosome binding site and the target protein, and the nucleotide sequence of the signal peptide is shown in SEQ ID NO.4.
[0040] Beneficial effects
[0041] Compared to E. coli, the present invention uses the safer Corynebacterium glutamicum as an expression system, and through the comprehensive application of promoter screening, RBS, AS optimization and tandem combination strategy of gene expression cassettes, the collagen production of Corynebacterium glutamicum is improved. Specifically:
[0042] (1) The present invention uses the tac promoter and the RBS sequences (including AS sequences) shown in SEQ ID NOs. 26 to 30 to construct recombinant bacteria with a collagen protein yield of more than 244 mg / L, with a maximum yield of 514 mg / L, which is 6 times higher than the yield of the unmodified strain. The tacM promoter and the RBS sequences (including AS sequences) shown in SEQ ID NOs. 31 to 35 to construct recombinant bacteria with a collagen protein yield of more than 86 mg / L, with a maximum yield of 206.3 mg / L.
[0043] (2) Based on the tac promoter and the RBS sequences shown in SEQ ID NOs. 26 to 30, the present invention further uses a combination of multiple target genes connected in series using a gene expression cassette to construct a recombinant bacterial collagen protein with a maximum yield of 697 mg / L;
[0044] (2) The present invention ensures the correct folding and thermal stability of the protein structure after optimizing the expression elements during recombinant expression, while increasing the protein expression level. BRIEF DESCRIPTION OF THE DRAWINGS
[0045] Figure 11A is the growth curve of different recombinant strains; 1B is the SDS-PAGE image of the fermentation supernatant of different recombinant strains; 1C is the integrated gray value of the target protein band;
[0046] Figure 2 Optimization of fermentation time of recombinant strains with different promoters; 2A to 2E are SDS-PAGE images of supernatants of recombinant strains at different fermentation times, where 2A to 2E correspond to the introduction of promoters tac-R0, tacM, P7-R0, H36, and NCg1676, respectively; 2F is SDS-PAGE image of supernatants of different recombinant strains under optimal fermentation; 2G is SDS-PAGE image after purification; 2H is the yield of purified VB;
[0047] Figure 3 Figure 3A shows the results of shake flask fermentation of recombinant strains with different RBS sequences; Figure 3B shows the growth curve of recombinant strains modified with the tac promoter and different RBS sequences; Figure 3C and Figure 3D show the SDS-PAGE images of the fermentation supernatants of the modified recombinant strains; Figures 3E and 3F show the VB yields of the purified recombinant strains with RBS modifications.
[0048] Figure 4 Figure 4 is the fermentation expression of multi-gene tandem recombinant strains; 4A is a schematic diagram of the multi-gene expression cassette structure; 4B is an SDS-PAGE image of the fermentation supernatant of the multi-gene tandem recombinant strain; 4C is the VB yield after purification of the multi-gene tandem recombinant strain;
[0049] Figure 5 Figure 5 is the characterization of VB expressed by recombinant bacteria after enzyme digestion; 5A is the SDS-PAGE image of VB after enzyme digestion; 5B is the mass spectrometry identification of VB after enzyme digestion; 5C is the CD spectrum at 4°C; 5D is the thermal melting curve measured at 220 nm. DETAILED DESCRIPTION
[0050] The following describes preferred embodiments of the present invention. It should be understood that the embodiments are for better explanation of the present invention and are not intended to limit the present invention.
[0051] The raw materials used in the embodiment are:
[0052] 1. Strains and plasmids:
[0053] Escherichia coli JM109, E. coli BL21, and Corynebacterium glutamicum ATCC13032 are all preserved in our laboratory and can also be purchased through commercial channels.
[0054] The pXMJ19-PorB-VB plasmid used in the present invention is based on pXMJ19 as the skeleton and tac as the promoter, and is connected to the target protein recombinant collagen VB, and the signal peptide PorB is introduced at the front end of the recombinant collagen VB. The specific construction method is recorded in the document "Optimization of signal peptide and fermentation conditions to promote the secretory expression of collagen in Corynebacterium glutamicum [J]. Food and Fermentation Industries, 2022, 48(15): 9-17. DOI: 10.13995 / j.cnki.11-1802 / ts.031128"; wherein, the amino acid sequence of recombinant collagen VB is shown in SEQ ID NO.1, the nucleotide sequence is shown in SEQ ID NO.2, the nucleotide sequence of signal peptide PorB is shown in SEQ ID NO.4, and the nucleotide sequence of tac promoter is shown in SEQ ID NO.58.
[0055] Promoter, terminator sequence, source:
[0056] tac was preserved in the laboratory. The tac promoter sequence (SEQ ID NO.58) in the recombinant strain tac-VB is:
[0057] TTGACAATTAATCATCGGCTCGTATAATGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGAATTAATT;
[0058] tacM has been disclosed in the document "ia H, Li H, Zhang L, Xu D. Development of a Novel Gene Expression System for Secretory Production of Heterologous Proteins via the General Secretory (Sec) Pathway in Corynebacterium Glutamicum. Iran J Biotechnol. 2018 Apr 18; 16(1): e1746. doi: 10.21859 / ijb.1746. PMID: 30555839; PMCID: PMC6217267.", and its promoter sequence (SEQ ID NO. 59) is:
[0059] TGAGCTGTTGACAATTAATCATCGTGTGGTACCATGTGTGGAATTGTGAGCGGATAA CAATT;
[0060] P7: Published in the literature “Rytter JV, Helmark S, Chen J, Lezyk MJ, Solem C, Jensen PR. Synthetic promoter libraries for Corynebacterium glutamicum. Appl Microbiol Biotechnol. 2014 Mar; 98(6): 2617-23. doi: 10.1007 / s00253-013-5481-x. Epub 2014 Jan 24. PMID: 24458563.”
[0061] NCgl1676, NCgl0226, Sod: Published in the literature “Li N, Zeng W, Xu S, Zhou J. Obtaining aseries of native gradient promoter-5'-UTR sequences in Corynebacterium glutamicum ATCC 13032. Microb Cell Fact. 2020 Jun 3; 19(1): 120. doi: 10.1186 / s12934-020-01376-3. PMID: 32493332; PMCID: PMC7268698.”
[0062] H36: Published in Yim SS, An SJ, Kang M, Lee J, Jeong KJ. Isolation of fully synthetic promoters for high-level gene expression in Corynebacterium glutamicum. Biotechnol Bioeng. 2013 Nov; 110(11): 2959-69. doi: 10.1002 / bit.24954. Epub 2013 Jun 3. PMID: 23633298.
[0063] H10: It has been reported in the literature "Wei L, Xu N, Wang Y, Zhou W, Han G, Ma Y, Liu J. Promoterlibrary-based module combination (PLMC) technology for optimization of threonine biosynthesis in Corynebacterium glutamicum.Appl MicrobiolBiotechnol.2018May;102(9):4117-4130.doi:10.1007 / s00253-018-8911-y.Epub2018Mar 21.PMID:29564525." Published in;
[0064] The nucleotide sequence of the terminator in the embodiment is UAA;
[0065] The primers used to construct the recombinant plasmids in the experiment were synthesized by Suzhou Jinweizhi Biotechnology Co., Ltd.
[0066] 2. Experimental reagents:
[0067] DL 10 000 DNA marker, Blunting Kination Ligation (BKL) Kit, and Premixed Protein Marker (Broad) were purchased from TaKaRa.
[0068] FastPure Bacteria DNA Isolation Mini Kit, 2× Phanta Max Master Mix, ClonExpress II One Step Cloning Kit, and Ultra GelRed (10000×) were purchased from Nanjing Novozymes Biotechnology Co., Ltd.;
[0069] Ezup column-based cell-free DNA extraction kit, chloramphenicol, and isopropyl-β-D-thiogalactopyranoside (IPTG) were purchased from Sangon Biotechnology (Shanghai) Co., Ltd.
[0070] Polyacrylamide gel electrophoresis (SDS-PAGE) kit and BCA protein concentration assay kit (enhanced) were purchased from Shanghai Biotech Biotechnology Co., Ltd.;
[0071] The GeneJET gel recovery kit was purchased from Thermo Fisher Scientific-CN. All other reagents were of analytical grade domestically produced unless otherwise specified.
[0072] Fermentation medium (pH 7): corn steep liquor powder 20 g / L, anhydrous ammonium sulfate 20 g / L, 3-morpholinepropanesulfonic acid 42 g / L, potassium dihydrogen phosphate 1 g / L, dimethyl phosphate 1 g / L, glucose 20 g / L, magnesium sulfate 0.25 g / L;
[0073] BHI seed medium (pH 7.4): tryptone 10 g / L, sodium chloride 5 g / L, disodium hydrogen phosphate 2.5 g / L, grape 2 g / L, bovine heart extract (brain heart extract powder) 500 mL / L (17.5 g / L).
[0074] Test method:
[0075] 1. Purification of collagen VB:
[0076] At the optimal fermentation time, centrifuge at 4°C and 11,000 rpm for 30 minutes, collect the fermentation supernatant, and filter through a 0.45 μm water filter. Then, affinity purification was performed using a His Trap™ HP 5 mL column. The specific steps are as follows: First, equilibrate with 15 column volumes of loading buffer (20 mmol / L Na2HPO4, 20 mmol / L NaH2PO4, 500 mmol / L NaCl, 10 mmol / L Liminazole, pH 7.4). Then, inject at a flow rate of 3 mL / min. After the injection is completed, equilibrate with loading buffer. Next, remove impurities with 10% v / v elution buffer (20 mmol / L Na2HPO4, 20 mmol / L NaH2PO4, 500 mmol / L NaCl, 500 mmol / L Liminazole, pH 7.4). Finally, the target protein was obtained by gradient elution, and the purification status was verified by SDS-PAGE.
[0077] 2. Quantitative analysis of collagen VB
[0078] In this study, the fermentation supernatants were subjected to SDS-PAGE and the grayscale values of protein bands were analyzed and calculated using ImageJ software to compare the differences in the expression of collagen VB mediated by different recombinant strains. Subsequently, the BCA protein content assay was used to accurately quantify the yield of purified collagen.
[0079] 3. Trypsin digestion
[0080] The enzymatic digestion method is consistent with the enzymatic digestion method in patent CN114480409B. The purified collagen VB is digested with trypsin and then vacuum-freeze-dried after verification by SDS-PAGE.
[0081] 4. MALDI-TOF mass spectrometry detection
[0082] The lyophilized collagen sample was dissolved in an ultrapure solution to make 1 mg / mL, and the molecular weight was determined by AB Sciex4800 mass spectrometer in linear mode.
[0083] 5. Circular dichroism detection
[0084] The lyophilized collagen sample was dissolved in 10 mmol / L PB buffer at pH 7.4 to make a 1 mg / mL solution. After equilibration at 4°C for more than 24 hours, circular dichroism spectroscopy was used to characterize the secondary structure of the collagen and determine Tm. The full wavelength of the sample in the range of 190 nm-260 nm was scanned below 4°C, with a step size of 1 nm and an average scan time of 2 ns. The secondary structure of the protein was determined based on the characteristic absorption peaks of the full wavelength. The wavelength was set to 225 nm, the temperature range was 10-70°C, the heating rate was 1°C / min, and equilibrium was performed at each temperature for 5 seconds. The absorbance of the sample was recorded to obtain a thermal curve, and Tm was obtained by fitting the first-order derivative of the thermal curve.
[0085] 6. Shake flask fermentation
[0086] The method is consistent with the literature "Optimization of signal peptide and fermentation conditions to promote secretory expression of collagen in Corynebacterium glutamicum [J]. Food and Fermentation Industries, 2022, 48(15): 9-17." Specifically:
[0087] Constitutive promoter strain: Use BHI seed solution to culture the recombinant strain overnight, transfer the fermentation medium to a 50mL / 500mL baffled shake flask, and make the initial OD of the fermentation medium 600 The concentration of 0.1 was used, and the culture was carried out in a shaking flask at 30°C and 200 r / min for 72 h;
[0088] Inducible promoter strain: Use BHI seed solution to culture the recombinant strain overnight, transfer the fermentation medium to a 50mL / 500mL baffled shake flask, and make the initial OD of the fermentation medium 600 The OD value was 0.1, and the culture was carried out at 30℃ and 200r / min in a shaking flask. 600 When the pH value was 6, IPTG was added at a final concentration of 0.5 mmol / L, and the temperature was changed to 28°C for 48 h.
[0089] Example 1: Construction of recombinant Corynebacterium glutamicum expressing collagen based on different promoters
[0090] 1. Screening promoters
[0091] The FastPure Bacteria DNA Isolation Mini Kit was used to extract the C. glutamicum ATCC13032 genome. Primers were designed using the genome as a template. The primer sequences are shown in Table 1. Sequences of the endogenous promoters NCgl1676, NCgl0226, and sod were amplified. The amplified endogenous promoter sequences were homologously recombined with the plasmid pXMJ19-PorB-VB to replace the original tac promoter in the plasmid. The recombinant plasmids were transformed into E. coli JM109, and positive transformants were selected and verified by sequencing.
[0092] Using the plasmid pXMJ19-PorB-VB as a template, primers were designed. The primer sequences are shown in Table 1. PCR amplification yielded recombinant plasmids carrying the exogenous inducible promoters tacM, tac, and P7, and the constitutive promoters H36 and H10. The recombinant plasmids were transformed into E. coli JM109, and positive transformants were selected and verified by sequencing. This resulted in the construction of pXMJ19-PorB-VB recombinant plasmids carrying different promoter sequences.
[0093] Table 1 Promoter primers
[0094]
[0095] 2. Construction of recombinant strains with different promoters
[0096] The sequencing-verified recombinant plasmid in 1 was electroporated into C. glutamicum ATCC13032 competent cells to construct recombinant strains with different promoters. The recombinant strains were plated on LB medium containing 15 μg / mL chloramphenicol and cultured for 36 hours. Positive transformants were obtained by resistance screening and named Promoter-VB according to the promoter name, where VB is a recombinant collagen protein with an amino acid sequence as shown in SEQ ID NO. 1 and a nucleotide sequence as shown in SEQ ID NO. 2. For example, the strain C. glutamicum ATCC13032 / pXMJ19-PtacM-PorB-VB containing the recombinant promoter tacM was named tacM-VB.
[0097] 3. Recombinant strain yield detection
[0098] Using tac-VB as a control strain, the recombinant strains of different promoters constructed in step 2 were tested. Single colonies were picked and transferred to BHI seed medium, cultured overnight at 30°C, 200 rpm for 11 hours, transferred to fermentation medium, and fermented in shake flasks. Samples were taken every 8 hours to measure OD. 600 And draw a growth curve.
[0099] Growth curve results are as follows Figure 1 As shown in A, each recombinant strain grew rapidly in the first 32 hours, and the total number of bacteria tended to be stable between 32 and 48 hours. The supernatant of the 48-hour fermentation was subjected to SDS-PAGE and grayscale analysis of protein bands. The results are shown in Figure 1 As shown in Figures B and 1C, the protein expression levels mediated by the tacM, H36, H10, and NCgl1676 promoters were all higher than those of the tac-mediated control strain. ImageJ analysis of the integrated dendity of the target protein bands showed that the expression level of the tacM strain was approximately three times that of the control strain tac-VB.
[0100] 4. Unify the RBS sequence of inducible promoters
[0101] according to Figure 1 The grayscale values of the protein band C show that the inducible promoters tac, tacM, and P7 differ significantly in their expression levels when mediating collagen VB. Further analysis suggests that this may be due to differences in their ribosome binding site (RBS) sequences. As a key element in controlling the rate of translation initiation, the RBS influences ribosome binding and promoter complex formation, thereby affecting protein expression.
[0102] Therefore, the recombinant strains were reconstructed according to the methods 1 and 2. The primer sequences are shown in Table 1. The RBS sequences of the tac promoter and the P7 promoter were changed to the same sequence as the RBS of the tacM promoter (i.e., AAAGGA). The recombinant strains C. glutamicum ATCC13032 / pXMJ19-Ptac-R0-PorB-VB and C. glutamicum ATCC13032 / pXMJ19-P7-R0-PorB-VB were constructed and named tac-R0-VB and P7-R0-VB, respectively.
[0103] 5. Yield detection
[0104] The recombinant strains with promoters tac-R0, tacM, P7-R0, H36, and NCgl1676 prepared in 2 and 4 were fermented in shake flasks, and samples were taken every 12 hours to measure OD 600 , detect the protein expression levels of strains with each promoter at different fermentation times.
[0105] The protein detection results of the recombinant strains with promoters tac-R0, tacM, P7-R0, H36, and NCgl1676 at different fermentation times correspond to Figure 2 A, 2B, 2C, 2D, 2E.
[0106] The results showed that the expression level of recombinant collagen VB mediated by the inducible promoters tac-R0, tacM, and P7-R0 induced by IPTG reached the highest value at 48 hours of fermentation, and then the protein expression level decreased slightly with the extension of fermentation time; while the protein expression level mediated by the constitutive promoters H36 and NCgl1676 increased with the extension of fermentation time.
[0107] Figure 2 F is the SDS-PAGE analysis of the optimal fermentation time of each promoter recombinant strain. At the same time, in order to accurately quantify the VB production, the fermentation supernatant of each recombinant strain was purified. The results are shown in Figure 4. Figure 2 G, and the protein concentration was determined. The results were as shown in Figure 2 As shown in H.
[0108] The results showed that the strain tac-R0-VB (C.glutamicum ATCC13032 / pXMJ19-Ptac-R0-PorB-VB), mediated by the promoter tac-R0, had the highest VB production, reaching a maximum yield of 244 mg / L, followed by the strain tacM-VB (C.glutamicum ATCC13032 / pXMJ19-PtacM-PorB-VB), mediated by the tacM promoter, with a VB production of 143 mg / L.
[0109] Example 2: Improving collagen production in recombinant Corynebacterium glutamicum by modifying RBS (including AS sequence)
[0110] The strength of the RBS directly affects the efficiency of ribosome binding to mRNA, thereby affecting the translation level of the protein. In Example 1, after the RBS sequence of the promoter tac was optimized to AAAGGA, which is consistent with tacM, the protein expression level was significantly increased. Therefore, the RBS (including the AS sequence) was further modified to construct a recombinant strain with modified RBS (including the AS sequence).
[0111] The strains tac-R0-VB and tacM-VB prepared in Example 1 were used as optimized vectors of the RBS sequence (including the AS sequence) (the nucleotide sequence of the RBS sequence is shown in SEQ ID NO. 25). The sequence was used as the seed region of the RBS sequence and the online server RBS Calculator Version 2.1 (https: / / salislab.net / software / predict_rbs_library_calculator) was used to construct a AAAGGAN containing (6-9) A mutation library, where N (6-9) is 6 to 9 random bases, N (6-9)The AS sequence is included. Five RBS (including AS sequence) sequences of different strengths were selected for the promoter tac-R0 and promoter tacM, namely R1, R2, R3, R4, and R5, and the sequences are shown in Table 2. tac-R0 and tacM are unmodified RBS sequences (nucleotide sequences are shown in SEQ ID NO. 25). The two sequences are identical and are named Promoter-Rs based on the promoter and RBS sequences. Rs corresponds to the five RBS sequences of different strengths.
[0112] Table 2 RBS sequences and translation initiation rates
[0113]
[0114]
[0115] Table 3 Primers used for RBS and AS transformation
[0116]
[0117] According to the method of Example 1, primers were designed. The primers are shown in Table 3. Five recombinant bacteria using the tac promoter and RBS sequences of different strengths (including AS sequences) and five recombinant bacteria using the tacM promoter and RBS sequences of different strengths (including AS sequences) were constructed and screened. According to the promoter and RBS sequence, they were named tac-Rs-VB and tacM-Rs-VB, respectively, where Rs corresponds to 5 RBS sequences of different strengths. For example, strain tac-R1-VB is a recombinant strain using a tac promoter and a tac-R1 RBS sequence.
[0118] The above 10 recombinant strains were fermented in shake flasks and growth curves were drawn. Figure 3 As shown in A and 3B, the growth curve of the strain did not change significantly after RBS transformation. At the optimal fermentation time of 48 h, samples were taken for SDS-PAGE analysis. The results were as follows Figure 3 As shown in C and 3D, the results showed that the protein expression levels of the tac-Rs-VB strains after RBS modification were increased to varying degrees; while among the tacM-Rs-VB strains after RBS modification, only the expression level of tacM-R5-VB was increased, while the expression levels of the other strains were significantly decreased.
[0119] The fermentation supernatants of 10 recombinant strains were purified and the VB production was determined, with tac-VB as a control. The results are shown in Figure 2. Figure 3As shown in Figures E and 3F, the expression levels of the recombinant strains with the tac promoter were: tac-R0-VB 244 mg / L, tac-R1-VB 467 mg / L, tac-R2-VB 393 mg / L, tac-R3-VB 369 mg / L, tac-R4-VB 481 mg / L, tac-R5-VB 514 mg / L, among which the tac-R5-VB strain had the highest expression level, which was about 6 times higher than that of tac-VB 67.3 mg / L; the expression levels of the recombinant strains with the tac promoter were: tacM-VB 143 mg / L, tacM-R1-VB 120.3 mg / L, tacM-R2-VB 91.3 mg / L, tacM-R3-VB 86 mg / L, tacM-R4-VB 51mg / L, tacM-R5-V-B206.3mg / L, among which tacM-R5-VB had the highest expression level.
[0120] Example 3: Increasing the expression of recombinant Corynebacterium glutamicum collagen by serial combination of multiple gene expression cassettes
[0121] By constructing a multi-gene expression cassette for the recombinant collagen expression system of Corynebacterium glutamicum, the protein expression level was further improved. The recombinant strain tac-R5-VB prepared in Example 2 was taken, and multiple target gene expression units with the same sequence were inserted after the promoter tac and the lactose operon. The multi-gene expression cassette structure was Figure 4 As shown in A; wherein, the structure of the target gene expression unit is: RBS sequence (R5)-signal peptide (porB)-target gene (VB); this strategy can increase the copy number of the target gene in the host cell.
[0122] 1. Construction of tandem combinations of multiple gene expression cassettes
[0123] Based on the recombinant strain tac-R5-VB, recombinant strains with two and four target gene expression units in series were designed and named tac-2B and tac-4B, respectively. The nucleotide sequences of the multi-gene expression cassettes of strains tac-2B and tac-4B are shown in SEQ ID NO.56 and SEQ ID NO.57. SDS-PAGE analysis was performed under the optimal fermentation time, and the results were as follows: Figure 4 As shown in Figure B, after tandem expression, the expression levels of recombinant collagen VB were increased. After purification, the average protein yields of the recombinant strains tac-2B and tac-4B reached 620 mg / L and 697 mg / L, respectively, which were increased by 106 mg / L and 193 mg / L compared to before tandem expression (tac-R5-VB).
[0124] 2. Characterization of recombinant collagen VB
[0125] The collagen VB prepared by the recombinant bacteria tac-4B constructed in 1 was used to verify whether the optimization of the expression element affected the correct folding and expression of the recombinant collagen.
[0126] The purified VB was digested with trypsin and its purity was verified by SDS-PAGE. Figure 5 As shown in A, the results showed that after VB enzyme digestion, a single band with a molecular weight of approximately 12 kDa was obtained.
[0127] The molecular weight was identified by MALDI-TOF, and the mass spectrometry results were as follows: Figure 5 As shown in B, the actual molecular weight of the collagen domain B after the folding domain V-domain was removed was 7949.87 g / mol, and the theoretical molecular weight of the control collagen domain B was 7949.52 g / mol, confirming that the protein after enzyme cleavage was the target protein.
[0128] The secondary structure of collagen domain B was verified by circular dichroism spectroscopy. Figure 5 As shown in Figure C, collagen domain B exhibits a typical triple helical structure, with a characteristic positive absorption peak at 220 nm, indicating that collagen domain B is correctly folded to form a triple helical structure.
[0129] Scanning the thermal curve of collagen solution from 4℃ to 80℃ at 220nm, the results are as follows Figure 5 As shown in Figure D, the Tm value of collagen obtained after fitting is 26.35°C, which is similar to the results reported in the literature "Optimization of collagen expression and cross-linking by introducing non-natural amino acids [J]. Chinese Journal of Biotechnology, 2021, 37(09): 3231-41", indicating that the optimization of expression elements did not affect the correct folding and expression of recombinant collagen.
[0130] Example 4: Expression of different collagens using recombinant Corynebacterium glutamicum
[0131] Based on the strain tac-4B constructed in Example 3, the target protein was changed to other collagen proteins, the amino acid sequence of which was shown in any one of SEQ ID NOs. 60 to 66, and its yield and protein structure were detected.
[0132] The results showed that the protein production of the strains after optimizing the expression elements increased by more than 2 times compared with the unmodified strains, and the protein structure did not change.
[0133] The sequences used in the present invention are:
[0134] SEQ ID NO.1 (VB amino acid sequence):
[0135] HHHHHHADEQEEKAKVRTELIQELAQGLGGIEKKNFPTLGDEDLDHTYMTKLLTYLQEREQAENSWRKRLLKGIQDHALDLVPRGSPGPRGEQGPQGLPGKDGEAGAQGPAGPMGPAGFPGERGEKGEPGTQGAKGDRGETGPVGPRGERGEAGPAGKDGERGPVGPAG*
[0136] SEQ ID NO.2 (V-B nucleotide sequence):
[0137] catcatcatcatcaccacgccgatgaacaagaagagaaagcaaaggtgcgcaccgaactgattcaagaactggcacaaggtctgggcggtatcgaaaagaagaacttcccgactttaggtgatgaggatttagatcacacctacatgaccaaactgctgacctatttacaagaacgcgaacaagctgaaaatagctggcgcaaacgtctgctgaaaggcatccaagatcatgcactggatctggttccgcgtggtagccccggtcctcgcggtgaacaaggtccgcaaggtctgccgggtaaagatggtgaagccggtgcacaaggtccggctggtcctatgggcccggccggctttccgggcgaacgtggtgaaaaaggcgaaccgggtacccaaggtgccaaaggtgatcgtggcgaaaccggtccggttggccctcgtggcgaacgcggtgaagctggtccggctggcaaagacggtgaacgtggtcccgttggtccggccggttaa
[0138] SEQ ID NO.3 (Lac operon nucleotide sequence):
[0139] TTGTGAGCGGATAACAA
[0140] SEQ ID NO.4 (porB signal peptide nucleotide sequence):
[0141] atgaagctttcacaccgcatcgcagcaatggcagcaaccgcaggcatcacagtggcagcattcgcagcacctgcttccgcatccgacttcaagctt
[0142] SEQ ID NO.56 (complete nucleotide sequence of tac-2B):
[0143]
[0144] SEQ ID NO.57 (complete nucleotide sequence of tac-4B):
[0145]
[0146] SEQ ID NO.60 (amino acid sequence of collagen HC1-1):
[0147] GARGLPGTAGLPGMKGHRGFPGERGLDGAKGDAGPAGPKGEPGSPGENGAPGQMGPRGPQGPPGPPGPKGNSGEPGAPGSKGDTGAKGEPGPVGVQGPPGPAGEEGKR
[0148] SEQ ID NO.61 (amino acid sequence of collagen HC1-2):
[0149] GFPGERGVQGPPGPAGPRGANGAPGNDGAKGDAGAPGAPGSQGAPGLQGMPGERGAAGLPPGPKGDRGDAGPKGADGSPGKDGVRGLTGPIGPPGPAGAPGDKGESGPS
[0150] SEQ ID NO.62 (amino acid sequence of collagen HC1-3):
[0151] GPAGFAGPPGADGQPGAKGEPGDAGAKGDAGPPGPAGPAGPPGPIGESGREGAPGAEGSPGRDGSPGAKGDRGETGPAGPPGFPGERGAPGPAGPAGPVGPVGARGPAGPQGPRGDKGETGEQGDRGIKGHRGFSGLQ
[0152] SEQ ID NO.63 (amino acid sequence of collagen HC2A):
[0153] GLTGPAGEPGREGSPGADGPPGRDGAAGVKGDRGETGAVGAPGAPGPPGDRGEAGAQGPMGPSGPAGARGIQGPQGPRGDKGEAGEPGERGLKGHRGFTGLQGLPGPPGPS
[0154] SEQ ID NO.64 (amino acid sequence of collagen HC3A):
[0155] GFPGMKGHRGFDGRNGEKGETGAPGLKGENGLPGENGAPGPMGPRGAPGERGSPGPKGDKGEPGPPGADGVPGKDGPRGPTGPIGPPGPAGQPGDKGEP
[0156] SEQ ID NO.65 (amino acid sequence of collagen HC3B):
[0157] GFPGMKGHRGFDGRNGEKGETGAPGLKGENGLPGENGAPGPMGPRGAPGERGAKGEPGPRGERGEAGIPGVPGAKGEDGKPGEPGPKGDAGAPGAPGPKGDAGAPGER
[0158] SEQ ID NO.66 (amino acid sequence of collagen HC-3C):
[0159] GFPGMKGHRGFDGRNGEKGETGAPGLKGENGLPGENGAPGPMGPRGAPGERGAKGEPGPRGERGEAGIPGVPGAKGEDGRDGNPGSDGLPGRDGSPGPKGDRGENGSP
[0160] SEQ ID NO.67 (nucleotide sequence of tac-R5-porB-VB):
[0161] ttgacaattaatcatcggctcgtataatgtgtggaattgtgagcggataacaatttcacacaggaaacagaattaattaaaggagatatttaatgaagctttcacaccgcatcgcagcaatggcagcaaccgcaggcatcacagtggcagcattcgcagcacctgcttccgcat ccgacttcaagcttcatcatcatcatcaccacgccgatgaacaagaagagaaagcaaaggtgcgcaccgaactgattcaagaactggcacaaggtctgggcggtatcgaaaagaagaacttcccgactttaggtgatgaggatttagatcacacctacatgaccaaactgctgac ctatttacaagaacgcgaacaagctgaaaatagctggcgcaaacgtctgctgaaaggcatccaagatcatgcactggatctggttccgcgtggtagccccggtcctcgcggtgaacaaggtccgcaaggtctgccgggtaaagatggtgaagccggtgcacaaggtccggctgg tcctatgggcccggccggctttccgggcgaacgtggtgaaaaaggcgaaccgggtacccaaggtgccaaaggtgatcgtggcgaaaccggtccggttggccctcgtggcgaacgcggtgaagctggtccggctggcaaagacggtgaacgtggtcccgttggtccggccggttaa
[0162] Although the present invention has been disclosed above in terms of preferred embodiments, it is not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be based on the definition of the claims.
Claims
1. A gene expression cassette, characterized in that The structure of the gene expression cassette includes: Promoter-(ribosome binding site-target protein) n -Terminator; Wherein, n represents quantity, and the value of n is 1, 2, 3 or 4; the nucleotide sequence of the ribosome binding site is shown as SEQ ID NO.26, SEQ ID NO.27, SEQ ID NO.28, SEQ ID NO.29, SEQ ID NO.30, SEQ ID NO.31, SEQ ID NO.32, SEQ ID NO.33, SEQ ID NO.34 or SEQ ID NO.
35.
2. The gene expression cassette according to claim 1, characterized in that The promoter includes: tac, tacM, P7, NCgl1676, NCgl0226, sod, H36, H10; optionally, the promoter is tac or tacM, and the nucleotide sequence is shown in SEQ ID NO.58 and SEQ ID NO.59; optionally, an operator is further connected between the promoter and the ribosome binding site, and the nucleotide sequence of the operator is shown in SEQ ID NO.3; optionally, a nucleotide sequence of a signal peptide is further connected between the ribosome binding site and the target protein, and the nucleotide sequence of the signal peptide is shown in SEQ ID NO.4; optionally, the amino acid sequence of collagen is shown in SEQ ID NO.1, SEQ ID NO.60, SEQ ID NO.61, SEQ ID NO.62, SEQ ID NO.63, SEQID NO.64, SEQ ID NO.65 or SEQ ID NO.
66.
3. A plasmid carrying the gene expression cassette according to any one of claims 1 to 2 or a cell carrying the gene expression cassette according to any one of claims 1 to 2.
4. Use of the gene expression cassette according to any one of claims 1 to 2 or the plasmid or cell carrying the gene expression cassette according to claim 3 in the preparation of collagen.
5. A recombinant bacterium, characterized in that The recombinant bacteria contains the gene expression cassette according to any one of claims 1 to 2; wherein the value of n is 1, 2, 3 or 4, the promoter is tac, the nucleotide sequence of the promoter is shown in SEQ ID NO.58, the nucleotide sequence of the ribosome binding site is shown in any one of SEQ ID NO.25 to 30, and the amino acid sequence of the target protein is shown in SEQ ID NO.1; optionally, the recombinant bacterial host is Corynebacterium glutamicum, the expression vector of the gene expression cassette is plasmid pXMJ19, and the amino acid sequence of the target protein can also be shown in any one of SEQ ID NO.60 to 66.
6. The recombinant bacterium according to claim 5, characterized in that A lactose operon is also connected between the promoter and the ribosome binding site, and the nucleotide sequence is shown in SEQ ID NO.3; a signal peptide nucleotide sequence is also connected between the ribosome binding site and the target protein, and the nucleotide sequence is shown in SEQ ID NO.
4.
7. A method for increasing collagen production, characterized in that: Collagen is prepared by fermentation using recombinant Corynebacterium glutamicum, wherein the recombinant Corynebacterium glutamicum contains the gene expression cassette according to any one of claims 1 to 2; wherein the value of n is 1, 2, 3 or 4, and the nucleotide sequence of the ribosome binding site is shown in any one of SEQ ID NOs. 26 to 30.
8. The method according to claim 7, characterized in that: The promoter in the gene expression cassette is: tac, tacM, P7, NCgl1676, NCgl0226, sod, H36, H10; optionally, the promoter is tac or tacM.
9. The method according to claim 7 or 8, characterized in that The target protein in the gene expression cassette is collagen, and the amino acid sequence of the collagen is shown in SEQ ID NO.1, SEQ ID NO.60, SEQ ID NO.61, SEQ ID NO.62, SEQ ID NO.63, SEQ ID NO.64, SEQ ID NO.65 or SEQ ID NO.
66.
10. The method according to any one of claims 7 to 9, characterized in that: In the gene expression cassette, an operator is connected between the promoter and the ribosome binding site, and the nucleotide sequence of the operator is shown in SEQ ID NO.3; a signal peptide nucleotide sequence is also connected between the ribosome binding site and the target protein, and the nucleotide sequence of the signal peptide is shown in SEQ ID NO.4.
